European partnerships are initiatives in which the EU, together with public and private partners, commit to jointly support the development and implementation of a research programme and innovation activities in a particular area.
Cluster 1 is where the most competitive projects are included, the classic collaborative projects from previous Framework Programs and which bring together researchers, companies, research centers and universities.
Eligible actions
- Personalized medicine.
- Conditions of the environment on health and how we affect the environment.
- Address the European Health Plan “One Health” against microbial resistance.
Partnerships
The Horizon Europe’s partnerships under Cluster 1 are:
- Innovative Health Initiative
- Global Health EDCTP3
- Transformation of Health Care Systems
- Risk Assessment of Chemicals
- ERA for Health
- Rare Diseases
- One-Health Antimicrobial Resistance
- Personalised Medicine
- Pandemic Preparedness
Name | Opening date | Next deadline | Deadline model | Link |
Financial support for Ecosystem Partners | 16/08/2023 | 14/11/2023 | single-stage | |
Safe & Sustainable by Design (SSbD) packaging and single use device solutions for healthcare products | 27/07/2023 | 08/11/2023, 23/04/2024 | two-stage | |
Sustainable circular development and manufacturing of healthcare products and their quantitative environmental impact assessment | 27/07/2023 | 08/11/2023, 23/04/2024 | two-stage | |
Patient-centric blood sample collection to enable decentralised clinical trials and improve access to healthcare | 27/07/2023 | 08/11/2023, 23/04/2024 | two-stage | |
Expanding translational knowledge in minipigs: a path to reduce and replace non-human primates in non-clinical safety assessment | 27/07/2023 | 08/11/2023, 23/04/2024 | two-stage | |
Inclusive clinical studies for equitable access to clinical research in Europe | 27/07/2023 | 08/11/2023, 23/04/2024 | two-stage | |
: Establishing novel approaches to improve clinical trials for rare and ultra-rare diseases | 27/07/2023 | 08/11/2023, 23/04/2024 | two-stage | |
Mission Ocean and Waters and Mission A Soil Deal for Europe – Joint demonstration of approaches and solutions to address nutrient pollution in the landscape-river-sea system in the Mediterranean sea basin | 17 January 2023 | 20 Sep. 2023 | single-stage | |
European Partnership on Rare Diseases | 12 January 2023 | 19 Sep. 2023 | single-stage | |
Mission Climate adaptation, Mission Ocean & waters and Mission Soil Deal for Europe – Joint demonstration of an integrated approach to increasing landscape water retention capacity at regional scale | 17 January 2023 | 20 Sep. 2023 | single-stage | |
Towards a holistic support to children and adolescents’ health and care provisions in an increasingly digital society | 30 March 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Validation of fluid-derived biomarkers for the prediction and prevention of brain disorders | 26 April 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Tackling high-burden for patients, under-researched medical conditions | 26 April 2023 | 19 Sep. 2023 | two-stage | |
Access to health and care services for people in vulnerable situations | 30 March 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Comparative effectiveness research for healthcare interventions in areas of high public health need | 26 April 2023 | 19 Sep. 2023 | two-stage | |
The role of environmental pollution in non-communicable diseases: air, noise and light and hazardous waste pollution | 30 March 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Pandemic preparedness and response: Adaptive platform trials for pandemic preparedness | 26 April 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Innovative non-animal human-based tools and strategies for biomedical research | 30 March 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Personalised prevention of non-communicable diseases – addressing areas of unmet needs using multiple data sources | 30 March 2023 | 19 Sep. 2023 11 April 2024 | two-stage | |
Improving modes of delivery, deployment, and uptake of vaccines through phase IV/implementation research | 27 June 2023 | 28 Sep. 2023 03 April 2024 | two-stage | |
Advancing point-of-care diagnostics to the market | 27 June 2023 | 28 Sep. 2023 03 April 2024 | two-stage |
Scope: Europe
Budget: 8.246 M€
Organism: European comission
Aim of the project: R+D projects in the field of Health-
BENEFICIARIES
Any type of organization can apply for funding from Horizon Europe as long as it has the operational and financial capacity to carry out the tasks it proposes.
TYPE AND AMOUNT OF FINANCING
Variable
ELIGIBLE EXPENSES
Direct and indirect costs.
Find out what they say about our work














